Skip to content

A Pumpkin Seed, Isoflavonoid and Cranberry Mix in LUTS/BPH

Prospective Multicenter Open-label One Arm Trial Investigating a Pumpkin Seed, Isoflavonoid and Cranberry Mix in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04146103
Enrollment
163
Registered
2019-10-31
Start date
2018-04-01
Completion date
2019-03-31
Last updated
2019-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia

Brief summary

The aim is to assess the efficacy of a mix of Pumpkin Seed Extract, Soy Germ Isoflavonoids and Cranberry (Novex®) in the management of mild to moderate LUTS in BPH patients. The patients will be evaluated based on the severity of LUTS, urological quality of life, and erectile function.

Detailed description

This is a single-arm prospective open-label trial investigating a combination of pumpkin seed, isoflavonoid and cranberry mix in improving LUTS, urological quality of life, and erectile function in BPH patients. The compound will be administered orally two tablets daily for 3 months. Recruited patients will be seen at 3 visits: initial visit (visit 1), 1-month visit (visit 2) and 3-month visit (visit 3) and their data will be collected in a dedicated case report form.

Interventions

DRUGNovex

Novex® made of Pumpkin Seed Extract 550mg, Soy Germ Isoflavonoids 50 mg and Cranberry 50mg. The dose is 2 tablets/day taken orally.

Sponsors

Saint-Joseph University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* mild to moderate LUTS due to BPH for at least 6 months at the initial visit * no previous therapy or are still symptomatic despite the current use of alpha-blockers

Exclusion criteria

* International Prostate Symptom Score (IPSS) \> 19 * Prostate cancer * Urethral stenosis

Design outcomes

Primary

MeasureTime frameDescription
IPSSAt 1 and 3 months visitsChange in IPSS

Secondary

MeasureTime frameDescription
IPSS subscoresAt 1 and 3 months visitsChange in IPSS subscores (voiding, filling, nocturia)
uQoLAt 1 and 3 months visitsChange in uQoL
IIEF-5At 1 and 3 months visitsChange in IIEF-5
Rate of ejaculatory dysfunction and orthostatic hypotensionAt 1 and 3 months visitsRate

Countries

Lebanon

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026